Drug Shortage Report for TEVA-TAMOXIFEN
Report ID | 219038 |
Drug Identification Number | 00851973 |
Brand name | TEVA-TAMOXIFEN |
Common or Proper name | TAMOXIFEN 20MG TABS |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | TAMOXIFEN |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | PP 30's and 100's |
ATC code | L02BA |
ATC description | HORMONE ANTAGONISTS AND RELATED AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2024-02-07 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-02-09 |
Company comments | Item is to be discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2024-02-09 | French | Compare |
v1 | 2024-02-09 | English | Compare |
Showing 1 to 2 of 2